目的 探讨引起巨细胞病毒(CMV)感染患儿听力损害的相关因素分析。方法 依据脑干听觉诱发电位(BAEP)检测结果将158 例CMV 感染患儿分为听力正常组(n=117,BAEP ≤ 35)和听力异常组(n=41,BAEP>35)。收集两组患儿一般资料、血常规、肝功能、尿液及乳汁病毒拷贝数等进行回顾性分析;绘制受试者工作特征曲线(ROC)预测导致BAEP 异常的CMV-DNA 病毒载量;采用Spearman 秩相关分析对尿CMV-DNA拷贝数与听力损害程度、血小板计数间进行相关性分析。结果 听力异常组血小板异常率、肝功能异常率和尿CMV-DNA 拷贝数均高于听力正常组(P<0.01)。ROC 分析结果显示,当尿CMV-DNA 拷贝数为1.415×106/mL时,预测病毒载量导致听力损伤的敏感性为46.3%,特异性为93.2%。相关性分析结果显示,听力损害的程度随着CMV-DNA 拷贝数的增加而增高(r=0.382,P<0.01);血小板计数和尿CMV-DNA 拷贝数之间存在负相关(r=-0.233,P=0.003)。结论 尿CMV-DNA 病毒载量可能与CMV 感染导致神经性听力障碍相关;当CMVDNA载量达到1.415×106/mL 时,更易出现听力损害。存在血小板减少的CMV 感染患儿,应加强听力监测。
Abstract
Objective To investigate the risk factors for hearing impairment induced by cytomegalovirus (CMV) infection in children. Methods One hundred and fifty-eight children diagnosed with CMV infection were enrolled as subjects. Based on the results of the brainstem auditory evoked potential (BAEP) test, patients were classified into normal hearing group (n=117; BAEP ≤35) and abnormal hearing group (n=41; BAEP >35). A retrospective analysis was performed on the general information, routine blood indices, liver function, copy number of CMV-DNA in urine and breast milk. The receiver operating characteristic (ROC) curve was used to predict the copy number of CMV-DNA resulting in abnormal BAEP. The Spearman rank correlation analysis was used to test the correlations of the copy number of CMV-DNA in urine with the degree of hearing impairment and platelet count. Results The incidence rates of platelet abnormality and abnormal liver function and the copy number of CMV-DNA in urine were significantly higher in the abnormal hearing group than in the normal hearing group (P<0.01). According to the ROC curve, the copy number of CMV-DNA in urine had a sensitivity of 46.3% and a specificity of 93.2% in predicting hearing impairment when it reached 1.415×106 per mL. The results of correlation analysis showed that the degree of hearing impairment was positively correlated with the copy number of CMV-DNA (r=0.382, P<0.01); the platelet count was negatively correlated with the copy number of CMV-DNA in urine (r=-0.233, P=0.003). Conclusions An increased copy number of CMV-DNA in urine might be a risk factor for hearing impairment induced by CMV infection. Children are likely to have hearing impairment when the copy number of CMV-DNA reaches 1.415×106 per mL. The monitoring of hearing should be strengthened in CMV-infected children with a decreased platelet count.
关键词
巨细胞病毒感染 /
脑干听觉诱发电位 /
听力损伤 /
儿童
Key words
Cytomegalovirus infection /
Brainstem auditory evoked potential /
Hearing impairment /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Engman ML, Malm G, Engstrom L, et al. Congenital CMV infection: prevalence in newborns and the impact on hearing deficit[J]. Scand J Infect Dis, 2008, 40(11-12): 935-942.
[2] Hagay ZJ, Biran G, Ornoy A, et al. Congenital cytomegalovirus infection: a long-standing problem still seeking a solution[J]. Am J Obstet Gynecol, 1996, 174(1 Pt 1): 241-245.
[3] Dollard SC, Schleiss MR, Grosse SD. Public health and laboratory considerations regarding newborn screening for congenital cytomegalovirus[J]. J Inherit Metab Dis, 2010, 33(Suppl 2): S249-S254.
[4] Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment[J]. J Clin Virol, 2008, 41(2): 57-62.
[5] Ross SA, Novak Z, Fowler KB, et al. Cytomegalovirus blood viral load and hearing loss in young children with congenital infection[J]. Pediatr Infect Dis J, 2009, 28(7): 588-592.
[6] Boppana SB, Fowler KB, Pass RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss[J]. J Pediatr, 2005, 146(6): 817-823.
[7] 中华医学会儿科学分会感染消化学组. 巨细胞病毒感染诊断 方案[J]. 中华儿科杂志, 1999, 37(7): 441.
[8] Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome[J]. Clin Infect Dis, 2013, 57 Suppl 4: S178-S181.
[9] Lipitz S, Hoffmann C, Feldman B, et al. Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection[J]. Ultrasound Obstet Gynecol, 2010, 36(6): 709-717.
[10] Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection[J]. J Pe¬diatr, 1997, 130(4): 624-630.
[11] Gabrielli L, Bonasoni MP, Santini D, et al. Human fetal inner ear involvement in congenital cytomegalovirus infection[J]. Acta Neuropathol Commun, 2013, 1: 63.
[12] Lanari M, Lazzarotto T, Venturi V, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns[J]. Pediatrics, 2006, 117(1): e76-e83.
[13] Rivera LB, Boppana SB, Fowler KB, et al. Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection[J]. Pediatrics, 2002, 110(4): 762-767.
[14] 李霄, 陈贻骥, 李禄全. 巨细胞病毒感染新生儿听力损害与 尿液病毒负荷量的相关性研究[J]. 中国当代儿科杂志, 2011, 13(8): 617-620.
[15] Harrison GJ. Current controversies in diagnosis, management, and prevention of congenital cytomegalovirus: updates for the pediatric practitioner[J]. Pediatr Ann, 2015, 44(5): e115-e125.
[16] Stronati M, Lombardi G, Garofoli F, et al. Pharmacokinetics, pharmacodynamics and clinical use of valganciclovir in newborns with symptomatic congenital cytomegalovirus infection[J]. Curr Drug Metab, 2013, 14(2): 208-215.
[17] Bate SL, Cannon MJ. A social marketing approach to building a behavioral intervention for congenital cytomegalovirus[J]. Health Promot Pract, 2011, 12(3): 349-360.
基金
国家自然科学基金(81170601;81571466);浙江省卫生高层次创新人才培养工程项目。
PDF(1266 KB)
